Journals / Diagnostic and Interventional Radiology / 2016 / Cilt: 22 - Sayı: 3

Magnetic resonance imaging of benign prostatic hyperplasia

Pages
215–219
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

MRI, with its advantage of multiplanar imaging and superior soft tissue contrast resolution, can be used in BPH patients for differentiation of BPH from prostate cancer, estimation of zonal and entire prostatic volumes, determination of the stromal/glandular ratio, detection of the enlargement locations, and classification of BPH types which may be potentially helpful in choosing the optimal treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Benign prostatic hyperplasia (BPH) is a common condition in middle-aged and older men and negatively affects the quality of life.
📊
Key Findings & Data:Afterwards, this classification was demonstrated using magnetic resonance imaging (MRI).
💡
Conclusion & Impact:MRI, with its advantage of multiplanar imaging and superior soft tissue contrast resolution, can be used in BPH patients for differentiation of BPH from prostate cancer, estimation of zonal and entire prostatic volumes, determination of the stromal/glandular ratio, detection of the enlargement locations, and classification of BPH types which may be potentially helpful in choosing the optimal treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Benign prostatic hyperplasia (BPH) is a common condition in middle-aged and older men and negatively affects the quality of life. An ultrasound classification for BPH based on a previous pathologic classification was reported, and the types of BPH were classified according to different enlargement locations in the prostate. Afterwards, this classification was demonstrated using magnetic resonance imaging (MRI). The classification of BPH is important, as patients with different types of BPH can have different symptoms and treatment options. BPH types on MRI are as follows: type 0, an equal to or less than 25 cm3 prostate showing little or no zonal enlargements; type 1, bilateral transition zone (TZ) enlargement; type 2, retrourethral enlargement; type 3, bilateral TZ and retrourethral enlargement; type 4, pedunculated enlargement; type 5, pedunculated with bilateral TZ and/or retrourethral enlargement; type 6, subtrigonal or ectopic enlargement; type 7, other combinations of enlargements. We retrospectively evaluated MRI images of BPH patients who were histologically diagnosed and presented the different types of BPH on MRI. MRI, with its advantage of multiplanar imaging and superior soft tissue contrast resolution, can be used in BPH patients for differentiation of BPH from prostate cancer, estimation of zonal and entire prostatic volumes, determination of the stromal/glandular ratio, detection of the enlargement locations, and classification of BPH types which may be potentially helpful in choosing the optimal treatment.

🔖

Cite This Article

GÜNEYLİ, S., WARD, E., THOMAS, S., YOUSUF, A. N., TRİLİSKY, I., PENG, Y., ANTİC, T., OTO, A. (2016). Magnetic resonance imaging of benign prostatic hyperplasia. Diagnostic and Interventional Radiology, Cilt: 22 - Sayı: 3, 215–219. https://ajindex.com/articles/200306

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132:474–479
  2. Roehrborn CG, McConnell JD. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughn EB Jr, et al, eds. Campbell’s urology. 8th ed. Philadelphia: WB Saunders Co., 2002; 1297–1330
  3. Grossfeld GD, Coakley FV. Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging. Radiol Clin North Am 2000; 38:31–47. [CrossRef] 4. Wasserman NF. Benign prostatic hyperplasia: a review and ultrasound classification. Radiol Clin North AM 2006; 44:689–710. [CrossRef] 5. Randall A. Surgical pathology of prostatic obstructions. Baltimore: Williams & Wilkins, 1931
  4. Wasserman NF, Spilseth B, Golzarian J, Metzger GJ. Use of MRI for lobar classification of benign prostatic hyperplasia: potential phenotypic biomarkers for research on treatment strategies. AJR Am J Roentgenol 2015; 205:564–571. [CrossRef] 7. Ling D, Lee JK, Heiken JP, Balfe DM, Glazer HS, McClennan BL. Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases. Radiology 1986; 158:103–107. [CrossRef] 8. McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol 1978; 15:340–345
  5. Selman SH. The McNeal prostate: a review. Urology 2011; 78:1224–1228. [CrossRef] 10. Walz J, Burnett AL, Costello AJ, et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol 2010; 57:179–192. [CrossRef] 11. Oelrich TM. The urethral sphincter muscle in the male. Am J Anat 1980; 158:229–246. [CrossRef] 12. Marks LS, Treiger B, Dorey FJ, Fu YS, deKernion JB. Morphology of the prostate: distribution of tissue components in hyperplastic glands. Urology 1996; 44:486–492. [CrossRef] 13. Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology 1989; 172:131–137. [CrossRef] 14. Aarnink RG, de la Rosette JJ, Huynen AL, Giesen RJ, Debruyne FM, Wijkstra H. Standardized assessment to enhance the diagnostic value of prostate volume; part I: morphometry in patients with lower urinary tract symptoms. Prostate 1996; 29:317–326. [CrossRef] 15. Peng Y, Shen D, Liao S, et al. MRI-based prostate